Articles of Interest

  • Alcyone Lifesciences announces allowance of first patent related to ReFlow system to treat hydrocephalus

    Alcyone Lifesciences, a leader in neural intervention systems for neurological conditions and an innovator in the treatment of hydrocephalus, announced that the United States Patent and Trademark Office has now allowed the first of several patent applications relating to its innovative ReFlow System.

    read this article
  • Medical device firm CVRx secures $113m in new financing

    Medical device firm CVRx has secured $113min new financing which will be used to expand its global commercial activities.

    read this article
  • Boston Scientific’s new Emblem MRI S-ICD system gets FDA approval

    The US Food and Drug Administration (FDA) has approved Boston Scientific's Emblem MRI subcutaneous implantable defibrillator (S-ICD) system.

    read this article
  • China’s Wide Line, Thubrikar partner for Optimum TAVI system

    Medical device firm Thubrikar Aortic Valve has signed a second license agreement with China-based Wide Line for the clinical testing, manufacturing and sales rights related to its Optimum transcatheter aortic valve implantation (TAVI) system.

    read this article
  • CyberHeart announces development agreement with National Cancer Center in Japan to treat cardiac arrhythmias

    CyberHeart announced its first development agreement in Asia, with the installation of the CyberHeart System at the National Cancer Center (NCC) in Tokyo.

    read this article
  • Medical device firm CVRx secures $113m in new financing

    Medical device firm CVRx has secured $113min new financing which will be used to expand its global commercial activities.

    read this article
  • China’s Wide Line, Thubrikar partner for Optimum TAVI system

    Medical device firm Thubrikar Aortic Valve has signed a second license agreement with China-based Wide Line for the clinical testing, manufacturing and sales rights related to its Optimum transcatheter aortic valve implantation (TAVI) system.

    read this article
  • DMC Heart Hospital offers naturally dissolving heart stent to patients with coronary artery disease

    The interventional cardiology team at Detroit Medical Center’s (DMC) Heart Hospital recently became one of the first in Michigan to offer patients with coronary artery disease a new treatment option that literally disappears over time.

    read this article
  • Sutter Health advances cardiovascular service by offering fully dissolving heart stent in Bay Area and Sacramento

    Sutter Medical Center, Sacramento and Mills-Peninsula Health Services, both affiliates of Sutter Health, will be among the first in the country to offer patients with coronary artery disease a new treatment option, the Abbott Absorb stent, which literally disappears in the body over time.

    read this article
  • CearFlow launches FDA-cleared PleuraFlow system for pediatric cardiothoracic surgery

    ClearFlow, a medical device company based in Anaheim, California, has announced that its PleuraFlow Active Clearance Technology is now available for the treatment of pediatric cardiothoracic surgery patients.

    read this article
  • STENTYS enrolls first patient in left main clinical trial

    STENTYS, a medical technology company commercializing the world’s first and only Self-Apposing coronary stent, announces that it has commenced enrolling patients in the TRUNC trial, which is designed to evaluate the long-term safety and efficacy of the Xposition S stent in the treatment of unprotected left main coronary artery disease.

    read this article
  • Mitralign completes enrollment in first phase of US early feasibility study on tricuspid repair

    Mitralign, an innovative developer of transcatheter tricuspid and mitral valve repair solutions, announced it has completed subject enrollment in the SCOUT, US early feasibility study.

    read this article
  • Essential Medical gets IDE approval from FDA to start trial of Manta large bore vascular closure device

    Essential Medical has secured investigational device exemption (IDE) approval from the US Food and Drug Administration (FDA) to start clinical trial of the Manta large bore vascular closure device.

    read this article
  • Abbott’s Absorb bioresorbable heart stent gets FDA approval

    Healthcare firm Abbott has received approval from the US Food and Drug Administration (FDA) for its Absorb bioresorbable heart stent.

    read this article
  • Medtronic to acquire Heartware International for $1.1bn

    Irish medical technology firm Medtronic has signed an agreement to acquire US-based HeartWare International for about $1.1bn.

    read this article
  • Medtec Europe 2016

    DirectMed will be at MedTec Europe click for more information

    read this article
  • COMPAMED 2016

    DirectMed will be at the Compamed Trade Fair click for more information

    read this article
  • Medical Manufacturing Asia 2016

    DirectMed will be at Medical Manufacturing Asia Exhibition & Conference in Singapore click for more information

    read this article
  • CorMatrix CanGaroo ECM envelope receives CE mark approval

    CorMatrix Cardiovascular Incorporated, a company specializing in its extracellular matrix (ECM) technology announced today that it has received CE mark approval for its CorMatrix CanGaroo ECM envelope.

    read this article